130 related articles for article (PubMed ID: 29053185)
1. Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.
Lawrence YR; Moughan J; Magliocco AM; Klimowicz AC; Regine WF; Mowat RB; DiPetrillo TA; Small W; Simko JP; Golan T; Winter KA; Guha C; Crane CH; Dicker AP
Cancer; 2018 Feb; 124(3):491-498. PubMed ID: 29053185
[TBL] [Abstract][Full Text] [Related]
2. Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.
Reyngold M; Winter KA; Regine WF; Abrams RA; Safran H; Hoffman JP; Mowat RB; Hayes JP; Kessel IL; DiPetrillo T; Narayan S; Chen Y; Ben-Josef E; Delouya G; Suh JH; Meyer J; Haddock MG; Feldman M; Gaur R; Yost K; Peterson RA; Sherr DL; Moughan J; Crane CH
Oncologist; 2020 Mar; 25(3):e477-e483. PubMed ID: 32162826
[TBL] [Abstract][Full Text] [Related]
3. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704.
Li D; Moughan J; Crane C; Hoffman JP; Regine WF; Abrams RA; Safran H; Liu C; Chang P; Freedman GM; Winter KA; Guha C; Abbruzzese JL
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):554-60. PubMed ID: 26725729
[TBL] [Abstract][Full Text] [Related]
4. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
Ohrling K; Edler D; Hallström M; Ragnhammar P
Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
[TBL] [Abstract][Full Text] [Related]
5. A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care.
de Geus SW; Bliss LA; Eskander MF; Ng SC; Vahrmeijer AL; Mahadevan A; Kent TS; Moser AJ; Callery MP; Bonsing BA; Tseng JF
J Gastrointest Surg; 2016 Jan; 20(1):85-92; discussion 92. PubMed ID: 26427374
[TBL] [Abstract][Full Text] [Related]
6. Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704.
Berger AC; Garcia M; Hoffman JP; Regine WF; Abrams RA; Safran H; Konski A; Benson AB; MacDonald J; Willett CG
J Clin Oncol; 2008 Dec; 26(36):5918-22. PubMed ID: 19029412
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
8. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.
Rutter CE; Park HS; Corso CD; Lester-Coll NH; Mancini BR; Yeboa DN; Johung KL
Cancer; 2015 Dec; 121(23):4141-9. PubMed ID: 26280559
[TBL] [Abstract][Full Text] [Related]
9. Interferon-based Adjuvant Chemoradiation for Resected Pancreatic Head Cancer: Long-term Follow-up of the Virginia Mason Protocol.
Rocha FG; Hashimoto Y; Traverso LW; Dorer R; Kozarek R; Helton WS; Picozzi VJ
Ann Surg; 2016 Feb; 263(2):376-84. PubMed ID: 25775069
[TBL] [Abstract][Full Text] [Related]
10. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract][Full Text] [Related]
11. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
[TBL] [Abstract][Full Text] [Related]
12. DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
Alexander BM; Wang XZ; Niemierko A; Weaver DT; Mak RH; Roof KS; Fidias P; Wain J; Choi NC
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):164-71. PubMed ID: 22000749
[TBL] [Abstract][Full Text] [Related]
13. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer.
Ahrendt SA; Brown HM; Komorowski RA; Zhu YR; Wilson SD; Erickson BA; Ritch PS; Pitt HA; Demeure MJ
Surgery; 2000 Oct; 128(4):520-30. PubMed ID: 11015084
[TBL] [Abstract][Full Text] [Related]
14. Survival impact of neoadjuvant therapy in resected pancreatic cancer: A Prospective Cohort Study involving 18,332 patients from the National Cancer Data Base.
Mirkin KA; Hollenbeak CS; Wong J
Int J Surg; 2016 Oct; 34():96-102. PubMed ID: 27573691
[TBL] [Abstract][Full Text] [Related]
15. Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer.
Ma SJ; Oladeru OT; Miccio JA; Iovoli AJ; Hermann GM; Singh AK
JAMA Netw Open; 2019 Aug; 2(8):e199126. PubMed ID: 31411712
[TBL] [Abstract][Full Text] [Related]
16. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK
Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy for pancreatic cancer.
Goodman MD; Saif MW
JOP; 2014 Mar; 15(2):87-90. PubMed ID: 24618424
[TBL] [Abstract][Full Text] [Related]
19. Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control.
Wo JY; Childs SK; Szymonifka J; Mamon HJ; Ryan DP; Blaszkowsky LS; Kwak EL; Ferrone CR; Allen JN; Zhu AX; Wolpin BM; Chan JA; Abrams TA; McCleary NJ; Fernandez-Del Castillo C; Hong TS
Pract Radiat Oncol; 2014; 4(2):e117-e123. PubMed ID: 24890357
[TBL] [Abstract][Full Text] [Related]
20. Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.
Stark AM; Doukas A; Hugo HH; Hedderich J; Hattermann K; Maximilian Mehdorn H; Held-Feindt J
Neurol Res; 2015 Feb; 37(2):95-105. PubMed ID: 24995467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
